iShares Global Healthcare ETF (IXJ)
80.50
+0.70 (+0.88%)
USD |
May 13, 20:00
Price Chart
Key Stats
Customize
| Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.46% | 0.09% | 2.906B | 150067.5 |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (All) |
| 1.21% | 5.00% | 281.02M | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks to track the S&P Global 1200 Health Care IndexTM. The fund generally invests at least 80% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index. The index measures the performance of companies that the index provider deems to be a part of the healthcare sector of the economy and that the index provider believes are important to global markets. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | iShares |
| Prospectus Benchmark Index | |
| S&P Global 1200 Healthcare Sector NR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Greg Savage | 13.34 yrs |
| Jennifer Hsui | 8.75 yrs |
| Alan Mason | 5.05 yrs |
| Amy Whitelaw | 2.75 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
14
281.02M
-4.429B
Category Low
8.106B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of April 30, 2021
Performance Versus Category
As of May 13, 2021. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
Edit comparables
As of May 13, 2021.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Johnson & Johnson | 6.72% | 170.20 | 0.14% |
| UnitedHealth Group Inc | 5.89% | 409.61 | 0.26% |
|
Roche Holding AG
|
3.52% | -- | -- |
| Pfizer Inc | 3.33% | 40.17 | 0.17% |
|
Novartis AG
|
3.27% | -- | -- |
| Abbott Laboratories | 3.18% | 117.99 | 0.46% |
| AbbVie Inc | 3.07% | 117.35 | 0.64% |
| Merck & Co Inc | 2.97% | 78.77 | 0.10% |
| Thermo Fisher Scientific Inc | 2.77% | 461.50 | 1.00% |
| Medtronic PLC | 2.56% | 124.95 | 0.61% |
News
Headline
Wire
Time (ET)
Basic Info
| Investment Strategy | |
| The investment seeks to track the S&P Global 1200 Health Care IndexTM. The fund generally invests at least 80% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index. The index measures the performance of companies that the index provider deems to be a part of the healthcare sector of the economy and that the index provider believes are important to global markets. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | iShares |
| Prospectus Benchmark Index | |
| S&P Global 1200 Healthcare Sector NR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Greg Savage | 13.34 yrs |
| Jennifer Hsui | 8.75 yrs |
| Alan Mason | 5.05 yrs |
| Amy Whitelaw | 2.75 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (5-13-21) | 1.21% |
| 30-Day SEC Yield (3-31-20) | Upgrade |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 25.93 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of May 11, 2021
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 11/13/2001 |
| Last Annual Report Date | 3/31/2020 |
| Last Prospectus Date | 8/17/2020 |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund |
|
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
News
Headline
Wire
Time (ET)